Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

Gut - 1 Nov 1996

Rasi G, DiVirgilio D, Mutchnick M G, Colella F, Sinibaldi-Vallebona P, Pierimarchi P, Valli B, Garaci E

Abstract excerpt

BACKGROUND: Monotherapy for chronic hepatitis C using interferon (IFN) results in a very small proportion of patients exhibiting a sustained response. Clinical trials assessing the benefit of combination drug therapy may provide evidence of improved treatment response over that seen with single drug treatment. AIM: To assess the response in patients with chronic hepatitis C to one year of combination treatment:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Follow-Up Studies
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Interferon-alpha

Share to Polymerase Chain Reaction

Share to RNA, Viral

Source

Open in PubMed Open full text

Identifiers

PMID: 9026482
DOI: 10.1136/gut.39.5.679
PMCID: PMC1383391

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.PMID 9026482Read ↗

Alpha interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.Semantic proximity Read ↗

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.Semantic proximity Read ↗

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.Semantic proximity Read ↗

Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland.Semantic proximity Read ↗

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.Semantic proximity Read ↗

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment.Semantic proximity Read ↗

Antiviral effect of lymphoblastoid interferon-alpha on hepatitis C virus in patients with chronic hepatitis type C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.